Investigating the Solvent Effect on Crystal Nucleation of Etoricoxib

被引:30
作者
Chai, Yinghui [1 ,2 ]
Wang, Liping [1 ,2 ]
Bao, Ying [1 ,2 ,3 ]
Teng, Rugang [1 ,2 ]
Liu, Yumin [1 ,2 ,4 ]
Xie, Chuang [1 ,2 ]
机构
[1] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China
[2] Coinnovat Ctr Chem & Chem Engn Tianjin, Tianjin 300072, Peoples R China
[3] Tianjin Univ, Tianjin Key Lab Modern Drug Delivery & High Effic, Tianjin 300072, Peoples R China
[4] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester M13 9PL, Lancs, England
基金
中国国家自然科学基金;
关键词
SELF-ASSOCIATION; POLYMORPHS; CRYSTALLIZATION; TOLBUTAMIDE; WATER; ACID;
D O I
10.1021/acs.cgd.8b01571
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Induction time measurement experiments for etoricoxib (ETR) were carried out in four solvents. The results suggest the crystal nucleation of ETR becomes increasingly more difficult in the order: toluene, acetone, acetonitrile, and ethanol, and this order is well correlated with the interfacial energies determined by the classical nucleation theory. The solute-solvent interaction was investigated by solution infrared spectroscopy, molecular dynamic simulations, and density functional theory computed 1:1 solute-solvent binding energies. The strength of binding energy at the sulfonyl on the ETR molecule is not only related to the infrared spectral shift of the sulfonyl band but also related to the nucleation rate. The needle-like crystal morphology along the b-axis of ETR form I in four solvents indicates that the molecular arrangement along the ac plane is extremely limited in cluster growth during nucleation. The sulfonyl, as a hydrogen bond acceptor, participates in the formation of several hydrogen bonds in the two-dimensional structure of the ac plane. Thus, the combination of solvent on the sulfonyl retards the nucleation of ETR. The stronger the solvent interacts with the sulfonyl on the ETR molecule, the more energy is required for desolvation, and the slower the ETR nucleation becomes.
引用
收藏
页码:1660 / 1667
页数:8
相关论文
共 22 条
[1]  
[Anonymous], 2012, MAT STUD 6 0
[2]   Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial [J].
Bickham, Kara ;
Kivitz, Alan J. ;
Mehta, Anish ;
Frontera, Nancy ;
Shah, Sandhya ;
Stryszak, Paul ;
Popmihajlov, Zoran ;
Peloso, Paul M. .
BMC MUSCULOSKELETAL DISORDERS, 2016, 17
[3]   Computational study of solvent effects on the molecular self-assembly of tetrolic acid in solution and implications for the polymorph formed from crystallization [J].
Chen, Jie ;
Trout, Bernhardt L. .
JOURNAL OF PHYSICAL CHEMISTRY B, 2008, 112 (26) :7794-7802
[4]  
Clas S. D., 2002, U. S. Patent, Patent No. [US6,441,002, 6441002]
[5]  
Crocker L. S., 2002, Patent, Patent No. [W002/096877A1, 002096877, 02/096877A1, 02096877]
[6]   Concerning the relationship between structural and growth synthons in crystal nucleation: Solution and crystal chemistry of carboxylic acids as revealed through IR spectroscopy [J].
Davey, R. J. ;
Dent, G. ;
Mughal, R. K. ;
Parveen, S. .
CRYSTAL GROWTH & DESIGN, 2006, 6 (08) :1788-1796
[7]  
Frisch M.J., 2016, GAUSSIAN 16
[8]   Polymorphs and hydrates of Etoricoxib, a selective COX-2 inhibitor [J].
Grobelny, Pawel ;
Mukherjee, Arijit ;
Desiraju, Gautam R. .
CRYSTENGCOMM, 2012, 14 (18) :5785-5794
[9]   Kinetic insights into the role of the solvent in the polymorphism of 5-fluorouracil from molecular dynamics simulations [J].
Hamad, S ;
Moon, C ;
Catlow, CRA ;
Hulme, AT ;
Price, SL .
JOURNAL OF PHYSICAL CHEMISTRY B, 2006, 110 (07) :3323-3329
[10]   Crystal Nucleation Rates from Probability Distributions of Induction Times [J].
Jiang, Shanfeng ;
ter Horst, Joop H. .
CRYSTAL GROWTH & DESIGN, 2011, 11 (01) :256-261